Clinical Trials on Refractory Malignancies
Total 4030 results
-
University Hospital TuebingenLudwig-Maximilians - University of Munich; University Hospital AugsburgCompletedRelapse of Hematological Malignancies
-
Regeneron PharmaceuticalsRecruiting
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
National University Hospital, SingaporeOtsuka Pharmaceutical Co., Ltd.Unknown
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
First Affiliated Hospital of Zhejiang UniversityUnknownRefractory NeoplasmsChina
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Solid TumorChina
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Solid TumorChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Malignant Solid NeoplasmUnited States
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Dr. Tapas K. Das GuptaCompletedRefractory Solid TumorsUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Cancer | Refractory CancerUnited States
-
Shenzhen Geno-Immune Medical InstituteUnknown
-
University of ZurichUniversity Hospital Inselspital, Berne; Swiss Paraplegic Centre Nottwil; Cantonal...Completed
-
First Affiliated Hospital of Zhejiang UniversityUnknownRefractory NeoplasmsChina
-
Hangzhou Sumgen Biotech Co., Ltd.Active, not recruitingRelapsed or Refractory Multiple Myeloma | Hematological MalignancyChina
-
Case Comprehensive Cancer CenterTerminatedGynecologic MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
AmgenCompleted
-
M.D. Anderson Cancer CenterNot yet recruitingBrain Malignancies | PseudoprogressionUnited States
-
University Hospital, CaenNot yet recruitingCardiovascular Diseases | Children, Only | Malignancies
-
Incyte CorporationRecruitingAdvanced MalignanciesSpain, United States, France, Italy, Belgium
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Wake Forest University Health SciencesCompleted
-
Case Comprehensive Cancer CenterFlorida International University; Community Foundation of BrowardRecruitingRelapsed Cancer | Refractory CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Solid TumorsUnited States
-
PharmaEngineCompletedRefractory Solid TumorsTaiwan
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterWithdrawnRefractory Solid TumorsKorea, Republic of
-
Myrexis Inc.CompletedRefractory Solid TumorsUnited States
-
National Institute of CancerologíaNational Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.CompletedRefractory Solid TumorsMexico
-
National Health Research Institutes, TaiwanNational Cheng-Kung University HospitalRecruiting
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
CStone PharmaceuticalsBayerCompletedAdvanced Refractory Solid TumorsAustralia
-
Eli Lilly and CompanyCompletedCancer | Refractory Solid TumorUnited States
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Systemic Mastocytosis | Recurrent... and other conditionsUnited States
-
Madeline FieldsRecruitingDrug Resistant Epilepsy | Refractory Epilepsy | Medically Refractory EpilepsyUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingActive Malignancies | Life Threatening Complication of the Malignancy or Its Treatments
-
BioMed Valley Discoveries, IncCompletedSolid Tumor MalignanciesUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedCancer MalignanciesUnited States
-
Ruijin HospitalUTC Therapeutics Inc.RecruitingRefractory Malignant Solid NeoplasmChina
-
Ruijin HospitalRecruitingRefractory Solid TumorsChina
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
SupremeCure Pharma Inc.WithdrawnRefractory Solid Tumor
-
SCRI Development Innovations, LLCBayerCompletedRefractory Solid TumorsUnited States
-
Vertex Pharmaceuticals IncorporatedNational Cancer Institute (NCI)WithdrawnRefractory Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States